ClinicalTrials.gov record
Completed Phase 2 Interventional

Intra-oral Treatment of OLP With Rivelin®-CLO Patches

ClinicalTrials.gov ID: NCT03592342

Public ClinicalTrials.gov record NCT03592342. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Study to Assess the Safety and Efficacy of Three Doses of Clobetasol Propionate When Administered Intra-orally Twice Daily in Patients With Oral Lichen Planus (OLP) Using Rivelin®-CLO Patches

Study identification

NCT ID
NCT03592342
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dermtreat
Industry
Enrollment
140 participants

Conditions and interventions

Interventions

  • Clobetasol Propionate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 27, 2018
Primary completion
Dec 19, 2019
Completion
Dec 19, 2019
Last update posted
Jul 13, 2020

2018 – 2019

United States locations

U.S. sites
14
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
QWay Research Hialeah Florida 33010
Vitae Research Center, LLC Miami Florida 33135
Valencia Medical & Research Center Miami Florida 33165
The Dental College of Georgia Augusta Georgia 30912
Tufts University, School of Dental Medicine Boston Massachusetts 02111
Brigham and Women's Hospital, Division of Oral Medicine and Dentistry Boston Massachusetts 02115
NYU College of Dentistry, Bluestone Center for Clinical Research New York New York 10010
UNC Dermatology and Skin Cancer Center Chapel Hill North Carolina 27516
Carolinas Center for Oral Health Charlotte North Carolina 28209
University of Pennsylvania Health System, Dept. Oral amd Maxillofacial Surgery Philadelphia Pennsylvania 19104
Texas A&M University (TAMU), College of Dentistry Dallas Texas 75246
UT Southwestern Medical Center Department of Surgery Dallas Texas 75390-9109
ENT Associates of Texas Frisco Texas 75035
The Oral and Facial Surgery Center Clearfield Utah 84105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03592342, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2020 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03592342 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →